• Cambridge Scholars Publishing

    "This is a great introduction to living with Type 1 diabetes both for healthcare professionals and people living with the condition. It covers all aspects of day-to-day management, including how to get the best out of the latest technology available. [A Guide to Type 1 Diabetes Management, Technology, and Everything Else You Need to Know is an] invaluable book that is highly recommended."

    - Chris Askew OBE, Chief Executive of Diabetes UK

Treating Autism with Bumetanide

In spite of its high incidence, extensive media coverage and major clinical burden to families, there is not a single approved European or American drug treatment of Autism Spectrum Disorders (ASDs). The dominant genetic and psychiatric approaches to treat ASDs have various limitations, suggesting that a novel global approach to understand and treat ASDs is warranted. Based on the authors’ converged expertise on brain development, ASD treatment and brain imaging, this book provides a fresh view of the disorder which is validated by experimental imaging and large clinical trials, culminating in the first large phase 3 final pediatric trial (on 400 children in EU countries and the US) using a repositioning of a drug used for decades to treat hypertension and edema. The convergence of experimental and clinical data on this disorder is unprecedented, confirming the potential of the drug to be the first pediatric treatment of ASDs.

After explaining the mechanisms underlying ASDs, we describe specific cases of children who, after treatment, considerably improved their sociability and reduced their agitation. The book also discusses the skepticism that the authors met from the tenants of pure genetics and psychiatry, and why the abyssal poverty of information on developmental disorders has hampered progress in understanding and treating ASD.


Yehezkel Ben-Ari is a leading neurobiologist, with over 40 years of experience working on brain development and disorders, particularly autism spectrum disorders. He has published more than 500 papers in leading scientific journals, and received awards from the French Medical Research Institute and the European and USA Foundations of Epilepsy. He is also Doctor Honoris Causae of the University of Liège, Belgium.

Eric Lemonnier is a pedo-psychiatrist with a master’s degree in neuroscience and habilitation. He has published 30 scientific articles and is a leader of autism spectrum disorder (ASD) treatments, notably in Britanny and Limoges, where directed Autism resource expert centers. He has treated thousands of children with ASD.

Nouchine Hadjikhani is a neuroscientist, Associate Professor of Radiology at Harvard Medical School (Boston, USA), and Professor of Experimental Child and Adolescent Psychiatry at the University of Gothenburg (Sweden). She also directed the Neuroscience Cognitive Center of the Brain Mind Institute, Switzerland, from 2006 until 2012. She has published over 140 papers and has been awarded the Leenards Prize for Scientific Research.

There are currently no reviews for this title. Please do revisit this page again to see if some have been added.

Buy This Book

ISBN: 1-5275-1890-6

ISBN13: 978-1-5275-1890-2

Release Date: 13th September 2023

Pages: 105

Price: £59.99

-
+